{
 "drug": "Ramelteon Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "03/19/2026",
 "dayN": 159,
 "cat": "Psychiatry",
 "companies": [
  "Takeda Pharmaceuticals USA Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "03/19/2026",
   "update_type": "New",
   "initial_posting_date": "03/19/2026",
   "package_ndc": "64764-805-10",
   "generic_name": "Ramelteon Tablet",
   "contact_info": "877-825-3327",
   "related_info": "Product is expected to be available through February 2027.",
   "openfda": {
    "application_number": [
     "NDA021782"
    ],
    "brand_name": [
     "ROZEREM"
    ],
    "generic_name": [
     "RAMELTEON"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "64764-805"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "RAMELTEON"
    ],
    "rxcui": [
     "577348",
     "603162"
    ],
    "spl_id": [
     "2021e7fb-108a-4783-9a37-8bc05bf28b28"
    ],
    "spl_set_id": [
     "9de82310-70e8-47b9-b1fc-6c6848b99455"
    ],
    "package_ndc": [
     "64764-805-30",
     "64764-805-10",
     "64764-805-22"
    ],
    "nui": [
     "N0000175743",
     "N0000000250"
    ],
    "pharm_class_epc": [
     "Melatonin Receptor Agonist [EPC]"
    ],
    "pharm_class_moa": [
     "Melatonin Receptor Agonists [MoA]"
    ],
    "unii": [
     "901AS54I69"
    ]
   },
   "update_date": "03/19/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Rozerem, Tablet, 8 mg (NDC 64764-805-10)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "03/19/2026",
   "update_type": "New",
   "initial_posting_date": "03/19/2026",
   "package_ndc": "64764-805-30",
   "generic_name": "Ramelteon Tablet",
   "contact_info": "877-825-3327",
   "related_info": "Product is expected to be available through June 2027.",
   "openfda": {
    "application_number": [
     "NDA021782"
    ],
    "brand_name": [
     "ROZEREM"
    ],
    "generic_name": [
     "RAMELTEON"
    ],
    "manufacturer_name": [
     "Takeda Pharmaceuticals America, Inc."
    ],
    "product_ndc": [
     "64764-805"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "RAMELTEON"
    ],
    "rxcui": [
     "577348",
     "603162"
    ],
    "spl_id": [
     "2021e7fb-108a-4783-9a37-8bc05bf28b28"
    ],
    "spl_set_id": [
     "9de82310-70e8-47b9-b1fc-6c6848b99455"
    ],
    "package_ndc": [
     "64764-805-30",
     "64764-805-10",
     "64764-805-22"
    ],
    "nui": [
     "N0000175743",
     "N0000000250"
    ],
    "pharm_class_epc": [
     "Melatonin Receptor Agonist [EPC]"
    ],
    "pharm_class_moa": [
     "Melatonin Receptor Agonists [MoA]"
    ],
    "unii": [
     "901AS54I69"
    ]
   },
   "update_date": "03/19/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Tablet",
   "presentation": "Rozerem, Tablet, 8 mg (NDC 64764-805-30)",
   "company_name": "Takeda Pharmaceuticals USA Inc.",
   "status": "To Be Discontinued"
  }
 ]
}